VVOS
VVOS
NASDAQ · Health Care

Vivos Therapeutics Inc

$1.55
+0.05 (+3.33%)
As of Feb 8, 2:27 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +1,291.0% upside
Low Target $14.61
Average Target $21.56
High Target $30.18
Current Price $1.55
Current
$1.55
Target
$21.56
$14.61 $21.56 avg $30.18
Scenario Analysis
Bear Case
$14.61
842.6%
Low target
Base Case
$21.56
+1,291.0%
Avg target
Bull Case
$30.18
+1,847.1%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$21.79
-92.9% from high
52-Week Low
$14.74
+-89.5% from low
Target vs 52W High
$21.56
-1.1% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%